Northpond Ventures III GP, LLC

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Bethesda, MD
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
Northpond Ventures III GP, LLC, By: /s/ Patrick Smerkers, Chief Financial Officer
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Northpond Ventures III GP, LLC

Form 4 holding Former 10% Owner

Kyverna Therapeutics, Inc.

Security class
Common Stock
Shares / value
2,805,426
Estimated value
Report date
12 Feb 2024
Price
Ownership
By: Northpond Ventures III, LP
Form 4 holding Former 10% Owner

Kyverna Therapeutics, Inc.

Security class
Common Stock
Shares / value
450,000
Estimated value
Report date
12 Feb 2024
Price
Ownership
By: Northpond Ventures, LP
Form 4 holding Former 10% Owner

Kyverna Therapeutics, Inc.

Security class
Series B Preferred Stock
Shares / value
0
Estimated value
Report date
12 Feb 2024
Price
Ownership
By: Northpond Ventures III, LP
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Northpond Ventures III GP, LLC

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .